MMA Infusion of Lidocaine for Treatment of Headache in Patients With Aneurysmal SAH

Summary

The purpose of the MIL-SAH trial is to evaluate the efficacy and safety of middle meningeal artery (MMA) lidocaine infusion for the treatment of headache in patients with aneurysmal subarachnoid hemorrhage (SAH). The trial aims to determine whether MMA lidocaine infusion reduces headache severity during the first 72 hours following endovascular aneurysm treatment compared with placebo.

Timeline

Start

2026-12

Primary completion

2029-12

Completion

2030-02

Drugs

Indications